EDAP TMS S.A. Delivers Focal One® Device For Focal Treatment Of Prostate Cancer To Hospital In Poland

Published: Feb 11, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LYON, France, Feb. 11, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the installation of its Focal One device at the ESKULAP Private Hospital in Bydgoszcz, Poland. Focal One is the first robotic HIFU device dedicated to the focal approach for prostate cancer therapy. It combines the three essential components to efficiently perform a focal treatment: state-of-the-art imaging to localized tumors with the use of magnetic resonance imaging (MRI) combined with real-time ultrasound, utmost precision of robotic HIFU treatment focused only on identified targeted cancer areas, and immediate feedback on treatment efficacy utilizing Contrast-Enhanced Ultrasound Imaging.

Help employers find you! Check out all the jobs and post your resume.

Back to news